PD-L1 in extracellular vesicles (TEVs) derived from colon and prostate cancer cells bound to PD-L1 mAbs and served as “decoys”, which were subsequently cleared by macrophages, causing the depletion of the antibodies and resulting in insufficient PD-L1 blockade and drug resistance (107). The gene discussed is CD274; the disease is prostate carcinoma.